L. Currie

发表

Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4° C with retention of in vitro functional activity

J. Harper, J. Connor, L. Currie, 1997, Transfusion.

Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study

L. Broemeling, C. Verschraegen, C. Bueso-Ramos, 2002, The Lancet.

Enhanced retention of in vitro functional activity of platelets from recombinant human thrombopoietin‐treated patients following long‐term cryopreservation with a platelet‐preserving solution (ThromboSol) and 2% DMSO

C. Bueso-Ramos, S. Vadhan-Raj, J. Connor, 1999, British journal of haematology.

Enhanced circulatory parameters of human platelets cryopreserved with second‐messenger effectors: an in vivo study of 16 volunteer platelet donors

David J. Yang, W. Tansey, D. Yang, 1999, British journal of haematology.

Recovery of in vitro functional activity of platelet concentrates stored at 4 ° C and treated with second‐messenger effectors

J. Connor, S. Livesey, L. Currie, 1996 .

Recovery of in vitro functional activity of platelet concentrates stored at 4 degrees C and treated with second-messenger effectors.

J. Connor, S. Livesey, L. Currie, 1996, Transfusion.

Prevention of monocyte adhesion and inflammatory cytokine production during blood platelet storage: an in vitro model with implications for transfusion practice.

E. Wood, J. Anderson, E. Colton, 2000, Journal of biomedical materials research.

Quality assessment of platelet concentrates supplemented with second‐messenger effectors

M. Lozano, R. González-Conejero, J. Connor, 1999, Transfusion.

Cryopreservation of single‐donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second‐messenger effectors: enhanced retention of in vitro functional activity

J. Harper, J. Connor, S. Livesey, 1998, Transfusion.